TITLE

Review: Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers prevent type 2 diabetes

PUB. DATE
May 2006
SOURCE
ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p64
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses a study which aims to determine whether angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) reduces risk for type 2 diabetes in patients with hypertension or other cardiovascular risk factors. 12 RCTs met the selection criteria for the study. 7 RCTs used ACE inhibitors and 5 used ARBs. These drugs were compared with placebo, diuretics, β-blockers, or calcium-channel antagonists. It was found that in patients with hypertension or cardiovascular risk factors, angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers prevent the development of type 2 diabetes.
ACCESSION #
21490779

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics